Sosei Group Corporation confirmed that a series of Executive Management changes have been approved at the Company's 32nd Shareholders' Meeting held on March 24, 2022 and are effective immediately. Mr. Chris Cargill, formerly the Company's Chief Financial Officer, is appointed as Chief Executive Officer, succeeding Mr. Shinichi Tamura who has been appointed as Chairman of the Board.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,486 JPY | -0.87% | +6.68% | +4.57% |
05-31 | Nxera Pharma to Receive $4.6 Million Milestone Payments From Centessa Pharmaceuticals | MT |
05-30 | Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.57% | 829M | |
-0.38% | 90.85B | |
-0.92% | 39.02B | |
-9.57% | 33.46B | |
-17.98% | 14.51B | |
-6.74% | 13.22B | |
-9.76% | 11.65B | |
-47.31% | 10.57B | |
+6.52% | 9.23B | |
+137.06% | 7.71B |
- Stock Market
- Equities
- 4565 Stock
- News Nxera Pharma Co., Ltd.
- Sosei Group Corporation Approves Executive Changes